Co-Diagnostics EVP Bohrer reports 3,657 shares
EVP of Finance & Accounting Daniel Bohrer reports 3,657 CODX shares owned, including 2,722 unvested RSUs with semiannual vesting into 2027–2028.
Rhea-AI Filing Summary
Co-Diagnostics, Inc. (CODX) reported an initial ownership statement for Daniel Bohrer, EVP of Finance & Accounting, showing direct ownership of 3,657 shares of common stock as of the reporting date. This amount includes 2,722 unvested restricted stock units (RSUs) granted under the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan.
The unvested RSUs comprise 2,500 RSUs awarded on April 26, 2024 and 2,834 RSUs awarded on August 11, 2025, of which 1,667 and 945, respectively, had previously vested. The April 26, 2024 award vests in equal amounts every six months from November 23, 2024 through May 23, 2027, and the August 11, 2025 award vests in equal amounts every six months from November 23, 2025 through May 23, 2028. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Bohrer Daniel
Role
EVP of Finance & Accounting
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock F1 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 3,657 shares (Direct)
Footnotes (1)
- F1. Includes 2,722 unvested Restricted stock units (RSUs) awarded to the Reporting Person pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan comprised of 2,500 awarded on April 26, 2024 and 2,834 awarded on August 11, 2025, of which 1,667 and 945, respectively, previously vested. Vesting of April 26, 2024 award occurs in equal amounts every six months beginning November 23, 2024 and ending on May 23, 2027. Vesting of August 11, 2025 award occurs in equal amounts every six months beginning November 23, 2025 and ending on May 23, 2028.
Key Figures
Total Co-Diagnostics shares owned: 3,657 shares
Unvested RSUs included in holdings: 2,722 RSUs
RSUs awarded April 26, 2024: 2,500 RSUs
+3 more
6 metrics
Total Co-Diagnostics shares owned
3,657 shares
Directly held by Daniel Bohrer following the reported holding entry
Unvested RSUs included in holdings
2,722 RSUs
Unvested restricted stock units included within the 3,657 total shares
RSUs awarded April 26, 2024
2,500 RSUs
Restricted stock units granted to Daniel Bohrer under the 2015 Long Term Incentive Plan
Previously vested from April 26, 2024 award
1,667 RSUs
Portion of the April 26, 2024 RSU grant that had vested prior to this report
RSUs awarded August 11, 2025
2,834 RSUs
Restricted stock units granted to Daniel Bohrer under the 2015 Long Term Incentive Plan
Previously vested from August 11, 2025 award
945 RSUs
Portion of the August 11, 2025 RSU grant that had vested prior to this report
Key Terms
Restricted stock units (RSUs), Long Term Incentive Plan, vesting
3 terms
Restricted stock units (RSUs) financial
"Includes 2,722 unvested Restricted stock units (RSUs) awarded to the Reporting Person"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Long Term Incentive Plan financial
"pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan comprised of 2,500"
A long term incentive plan is a company program that awards executives and key employees bonuses—often in stock, options, or cash—only if the business meets multi-year performance goals. It links management pay to company results—like tying a coach’s bonus to a team’s multi-season record—so investors monitor it for how leaders are motivated, potential share dilution, and signals about the company’s long-term priorities.
vesting financial
"Vesting of April 26, 2024 award occurs in equal amounts every six months"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Co-Diagnostics (CODX) report in this Form 3 for Daniel Bohrer?
The filing reports that EVP of Finance & Accounting Daniel Bohrer beneficially owns 3,657 shares of Co-Diagnostics common stock, held directly, including unvested restricted stock units granted under the company’s 2015 Long Term Incentive Plan.
What RSU grants for CODX are disclosed for Daniel Bohrer in this Form 3?
The Form 3 discloses RSU grants of 2,500 RSUs on April 26, 2024 and 2,834 RSUs on August 11, 2025 to Daniel Bohrer, under Co-Diagnostics’ 2015 Long Term Incentive Plan, with portions of each grant already vested.
What is the vesting schedule of Daniel Bohrer’s CODX RSUs?
The April 26, 2024 RSU award vests in equal amounts every six months from November 23, 2024 through May 23, 2027. The August 11, 2025 award vests in equal amounts every six months from November 23, 2025 through May 23, 2028.
Does this CODX Form 3 show any recent buy or sell transactions by Daniel Bohrer?
No. The Form 3 presents an initial holding of 3,657 CODX shares and related RSU grants. It does not report any specific purchase or sale transactions or a direction such as buy or sell.
Is there a Rule 10b5-1 trading plan associated with Daniel Bohrer’s CODX holdings?
No Rule 10b5-1 trading plan is reported. The filing’s plan checkbox is not marked, and the footnote describing Bohrer’s 3,657 CODX shares and RSUs does not reference any trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
